Apeiron Investment Group Ltd.

10% Owner · ATAI Life Sciences N.V.

Every open-market stock purchase Apeiron Investment Group Ltd. has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. Insiders sell for many reasons, but they buy with their own money for one — this page tracks where how the prices paid compare to where the stock trades now.

Total bought

$44.3M

Open-market buys

Companies

Last buy

Aug 14, 2025

Where the buys stand today

ATAI
ATAI Life Sciences N.V.
3 purchases totalling $44.3M at an average of $2.08 per share. See all insider buying in ATAI →
Avg price paid
$2.08
Latest price
—
Market cap
Unknown

All reported buys

Date	Ticker	Shares	Price	Value	Filing
Aug 14, 2025	ATAI	8,675,799	$2.19	$19.0M	SEC ↗
Mar 24, 2025	ATAI	1,800,000	$1.40	$2.5M	SEC ↗
Feb 14, 2025	ATAI	10,835,718	$2.10	$22.8M	SEC ↗

Get alerted the next time Apeiron Investment Group Ltd. — or any insider — buys

We watch every Form 4 as it hits SEC EDGAR and alert you when insiders cluster into the same stock.

Get alerts free See pricing

About this data

Figures are parsed from Apeiron Investment Group Ltd.'s Form 4 filings on SEC EDGAR (CIK 1845711) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.